Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 20;43(10):1665-1673.
doi: 10.12122/j.issn.1673-4254.2023.10.03.

[Icaritin increases radiosensitivity of nasopharyngeal carcinoma cells by regulating iron death]

[Article in Chinese]
Affiliations

[Icaritin increases radiosensitivity of nasopharyngeal carcinoma cells by regulating iron death]

[Article in Chinese]
T Hu et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To explore the radiosensitizing effect of icaritin on nasopharyngeal carcinoma (NPC) cells and the underlying mechanism.

Methods: MTT assay and clonal formation assay were used to evaluate the effect of icaritin on proliferation of human NPC HONE1 and HNE1 cells. The effects of icaritin treatment, γ-ray radiation, or both on production of reactive oxygen species (ROS), cell cycle distribution and apoptosis of the NPC cells were assessed using flow cytometry. The expressions of DNA damage markers γ-H2AX, cycle-related proteins CDC25C, p-CDC25C and cyclin B1, and ferroptosis markers ACSL4 and GXP4 were detected using Western blotting. A nude mouse model bearing subcutaneous HONE1 cell xenograft was used to observe the effect of icaritin and radiation on tumor growth.

Results: Icaritin dose-dependently inhibited the viability of the NPC cells and enhanced the inhibitory effect of radiation on cell proliferation. Flow cytometry and Western blotting showed that icaritin treatment prior to radiation significantly promoted ROS production and γ-H2AX expression in the NPC cells (P<0.001). Compared with radiation exposure alone, the combined treatment caused cell cycle arrest in G2 phase, down-regulated CDC25C and cyclin B1 expression, and up-regulated p-CDC25C expression in the cells (P<0.01), resulting also in increased cell apoptosis, enhanced expression of ferroptosis protein ACSL4 and lowered expression of GXP4 (P<0.001). In the tumor-bearing mice, icaritin treatment, compared with radiation alone, significantly reduced the tumor growth rate and decreased tumor weight (P<0.001).

Conclusion: Icaritin can enhance radiosensitivity of NPC cells both in vitro and in nude mice possibly by enhancing ROS production to promote iron death of the cells.

目的: 探索淫羊藿素对鼻咽癌细胞放射增敏作用以及机制。

方法: 通过MTT实验和克隆形成实验,观察淫羊藿素对鼻咽癌HONE1和HNE1细胞增殖能力的影响,筛选出给药剂量以及照射剂量。建立鼻咽癌细胞γ射线照射模型以及淫羊藿素给药模型,将细胞分为空白组、淫羊藿素组、照射组和淫羊藿素与照射联合组。通过流式细胞术检测4组细胞活性氧(ROS)的变化、周期分布以及细胞凋亡情况,通过Western blot实验检测DNA损伤标志蛋白γ-H2AX、周期相关蛋白CDC25C、p-CDC25C、和CyclinB1以及铁死亡标志蛋白ACSL4和GXP4的表达情况。构建HONE1细胞裸鼠皮下移植瘤模型,观察淫羊藿素与放射联合对肿瘤组织的生长情况的影响。

结果: 淫羊藿素以剂量依赖性方式抑制鼻咽癌细胞活力,增强放射对鼻咽癌细胞增殖能力的抑制作用。流式细胞术及Western blot实验显示,淫羊藿素与放射联合后促进鼻咽癌细胞ROS增多,γ-H2AX表达上调(P<0.001)。与单纯照射组相比,联合组会使鼻咽癌细胞发生G2期阻滞,CDC25C和CyclinB1表达下调,p-CDC25C表达上调(P<0.01)。联合组会促进鼻咽癌细胞发生细胞凋亡,铁死亡蛋白ACSL4表达上调而GXP4表达下调(P<0.001)。与空白组相比,其余3组的肿瘤生长速度明显减慢。与照射组相比,联合组肿瘤生长速度减慢,瘤体重量下降(P<0.001)。

结论: 淫羊藿素可在体内、体外均增强鼻咽癌对放射的敏感性,可能主要是通过增强细胞活性氧促进鼻咽癌细胞发生铁死亡来达到放射增敏的作用。

Keywords: ferroptosis; icaritin; nasopharyngeal carcinoma; radiosensitization; reactive oxygen species.

PubMed Disclaimer

Figures

图 1
图 1
淫羊藿素对鼻咽癌细胞细胞活力的影响 Effect of icaritin on viability of nasopharyngeal carcinoma cells. A: Molecular structure of icaritin. B: Effects of icaritin at different concentrations on viability of HONE1 and HNE1 cells (n=3).
图 2
图 2
淫羊藿素联合放射加强对鼻咽癌细胞的抑制作用 Inhibitory effect of icaritin combined with radiation at different doses on nasopharyngeal carcinoma cells assessed by MTT assay (A) and plate clone formation assay (B).
图 3
图 3
淫羊藿素联合照射增加鼻咽癌细胞活性氧 Icaritin combined with radiation increases reactive oxygen species (ROS) in nasopharyngeal carcinoma cells. A: Changes in ROS levels. B: Expression of DNAdamage marker γ-H2AX protein. ***P<0.001 vs IR group.
图 4
图 4
淫羊藿素和照射联合导致鼻咽癌细胞发生G2期阻滞 Icaritin combined with radiation causes cell cycle arrest in G2 phase of nasopharyngeal carcinoma cells. A: Effects of icaritin combined with radiation on cell cycle distribution in nasopharyngeal carcinoma cells. B: Expression of cell cycle arrest marker proteins CDC25C, pCDC25C and cyclin B1. **P<0.01, ***P<0.001 vs IR group.
图 5
图 5
淫羊藿素和照射联合促进鼻咽癌细胞发生凋亡 Icaritin combined with radiation promotes apoptosis of nasopharyngeal carcinoma cells. A: Effects of icaritin combined with radiation on apoptosis of nasopharyngeal carcinoma cells. B: Expression ofACSL4, GPX4, Bax and Bcl-2 proteins. **P<0.01, ***P<0.001 vs the IR group.
图 6
图 6
淫羊藿素和照射联合对裸鼠肿瘤组织生长的抑制作用 Icaritin enhances the inhibitory effect of radiation on tumor growth in nude mice. A: Timeline of treatment of the nude mice. B: Gross observation of the tumor tissues. C: Trends of changes of tumor volume. D: Tumor weight in the 3 groups. E: Curves of body weight changes of the mice in each group. F: Viscera index of the vital organs in each group. n=6. **P<0.01, ***P<0.001 vs the IR group.

Similar articles

Cited by

  • Natural anti-cancer products: insights from herbal medicine.
    Cui D, Zhang C, Zhang L, Zheng J, Wang J, He L, Jin H, Kang Q, Zhang Y, Li N, Sun Z, Zheng W, Wei J, Zhang S, Feng Y, Tan W, Zhong Z. Cui D, et al. Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y. Chin Med. 2025. PMID: 40490812 Free PMC article. Review.

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. doi: 10.3322/caac.21338. - DOI - PubMed
    1. 孙 维泽, 陶 群芬, 付 玉梅, et al. 1514例鼻咽癌患者临床资料分析. 世界最新医学信息文摘. 2019;19(66):314–5. doi: 10.19613/j.cnki.1671-3141.2019.66.191. - DOI
    1. Lee HM, Okuda KS, González FE, et al. Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol. 2019;1164:11–34. - PubMed
    1. Liu X, Tang L, Du XJ, et al. Changes in disease failure risk of nasopharyngeal carcinoma over time: analysis of 749 patients with long-term follow-up. J Cancer. 2017;8(3):455–9. doi: 10.7150/jca.17104. - DOI - PMC - PubMed

Publication types

LinkOut - more resources